Archive | xLM's ContinuousTV Weekly Newsletter

ContinuousOS

#0112: FDA's New AI Guidance and the Rise of Continuous AI Credibility in GxP Operations

Nagesh Nama, +2

•

Jun 12, 2026

LinkedIn Live

#0111: From Compliance Function to Strategic Influence - Key Insights from xLM Live with Mike Magee

Nagesh Nama, +1

•

Jun 3, 2026

#0110: Why GxP Manufacturing Cannot Afford to Lag Behind in the Age of AI Agents

Nagesh Nama, +2

•

May 28, 2026

#109: The Board’s View of Quality Risk: Governance, AI, and the New cGMP Playbook

Nagesh Nama, +1

•

May 21, 2026

#0108: AI-Driven Drug Discovery and Autonomous GxP Operations: How ContinuousOS Is Reshaping the Future of Pharma

Nagesh Nama, +1

•

May 13, 2026

FDA

#107: FDA's Real-Time Clinical Trial Revolution: A Wake-Up Call for the Life Sciences Industry

Nagesh Nama, +1

•

May 6, 2026

FDA Special Programs

#0106: From Vision to Reality: AI, Compliance, and the Reinvention of Pharma Manufacturing

Nagesh Nama, +1

•

Apr 29, 2026

#0105: Engineering Trust: Making AI Credible, Compliant, and Scalable (Part 4)

Nagesh Nama, +1

•

Apr 22, 2026

LinkedIn Live

#104: Designing the Future of API Manufacturing: Insights from PRG’s Digital Factory Vision

Nagesh Nama, +1

•

Apr 15, 2026

AI Regulations

#0103: AI Governance in Life Sciences : From Principles to Regulatory-Ready Execution (Part 3)

Nagesh Nama, +1

•

Apr 8, 2026

#0102: AI in Pharma R&D: Moving from Hype to Real Impact

Nagesh Nama, +1

•

Apr 3, 2026

AI Regulations

#0101: AI Governance in GxP: From Principles to Practice (Part 2)

Nagesh Nama, +1

•

Mar 26, 2026